PIOGLITAZONE HYDROCHLORIDE | A202467 | MACLEODS PHARMACEUTICALS LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Takeda Pharmaceutical Company Limited et al v. Macleods Pharmaceuticals Limited 7 patentsANDA 202467pioglitazone | S.D.N.Y. | 2011-05-06 | Terminated 2011-06-02 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.1144
per ea
Lowest NADAC/Unit
$0.0689
per ea
Brand NDCs
0
Generic NDCs
18
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 33342005607PIOGLITAZONE HCL 45 MG TABLET | $0.1144 | EA | Generic | — | 2026-06-17 |
| 33342005610PIOGLITAZONE HCL 45 MG TABLET | $0.1144 | EA | Generic | — | 2026-06-17 |
| 33342005615PIOGLITAZONE HCL 45 MG TABLET | $0.1144 | EA | Generic | — | 2026-06-17 |
| 16714064701PIOGLITAZONE HCL 45 MG TABLET | $0.1144 | EA | Generic | — | 2026-06-17 |
| 16714064702PIOGLITAZONE HCL 45 MG TABLET | $0.1144 | EA | Generic | — | 2026-06-17 |
| 16714064703PIOGLITAZONE HCL 45 MG TABLET | $0.1144 | EA | Generic | — | 2026-06-17 |
Showing 6 of 18 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.